Clinical Trials

685 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT07463313 2026-03-11

6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors

116 enrolled

Thymic epithelial tumor, Mediastinal Neoplasms, Thymoma

NCT05050162 2026-03-03

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Phase 2/3 Suspended

1,714 enrolled

Carcinoma, Oropharyngeal Neoplasms

NCT06115499 2026-01-07

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT06783140 2025-12-05

PLATINUM-CAN

10 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT06214572 2025-04-11

RUGB

249 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT06923475 2025-04-11

NEODISCO

150 enrolled

Cholangiocarcinoma, Klatskin Tumor

NCT06861777 2025-03-11

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

474 enrolled

Esophageal Squamous Cell Carcinoma

NCT06037980 2025-02-17

PURITY

300 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

101 enrolled 13 charts

Carcinoma, Uterine Cervical Neoplasms

NCT05255653 2024-11-29

RAINBO

1,615 enrolled

Endometrial Neoplasms

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

440 enrolled

Uterine Cervical Neoplasms

NCT06138028 2024-07-24

Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT02923258 2024-06-20

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

224 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT05057130 2024-04-01

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

50 enrolled

Sarcoma

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT02641847 2024-01-25

TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature

503 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05125055 2023-11-22

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

80 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02221999 2023-08-29

SHPD002

250 enrolled

Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT03380468 2023-07-20

ECTOP-1004

300 enrolled

Adenocarcinoma of Lung, Lung Neoplasms

NCT00385606 2023-03-23

Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

400 enrolled

Advanced Non-small Cell Lung Cancer

NCT00997906 2022-09-29

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

172 enrolled

Head and Neck Neoplasms

NCT05489848 2022-08-05

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

294 enrolled

Endometrial Neoplasms

NCT05433597 2022-06-27

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

172 enrolled

Nasopharyngeal Carcinoma

NCT05213312 2022-06-15

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

622 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Esophageal Squamous Cell Carcinoma

NCT04138992 2020-06-30

A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

150 enrolled

Disease Free Survival

NCT01631357 2019-11-05

CIK

96 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

716 enrolled

Pathologic Complete Response, Stomach Neoplasms

NCT01407822 2018-09-11

EMERGING

72 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03423849 2018-02-06

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

200 enrolled

Breast

Breast Neoplasms

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

1 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00160875 2017-05-04

Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

54 enrolled

Esophageal Neoplasms

NCT01704690 2017-04-07

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Phase 2/3 Terminated

4 enrolled

Esophageal Neoplasms

NCT00304135 2016-05-30

Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

34 enrolled

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms

NCT02250872 2016-04-20

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury

182 enrolled

Tumor-Agnostic

Neoplasms

NCT00861094 2015-12-18

Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

266 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01829178 2015-05-13

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

30 enrolled

Gastrointestinal Neoplasms

NCT00785421 2015-01-08

PROSPECT

312 enrolled

Pancreatic Neoplasms

NCT00939848 2014-10-27

ABC-03

124 enrolled

Biliary Tract Neoplasms

NCT01854203 2013-07-30

NPC

300 enrolled

Nasopharyngeal Carcinoma

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

259 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00843934 2012-10-19

ACE500

450 enrolled

Carcinoma, Hepatocellular

NCT00960284 2012-01-13

PACT-7

102 enrolled